Month: September 2020

No Picture
Trading Ideas

Manhattan’s Newest Skyscraper Opens Up to Dead Midtown

September 14, 2020 admin Comments Off on Manhattan’s Newest Skyscraper Opens Up to Dead Midtown

(Bloomberg) — SL Green Realty Corp. is opening its new $3.3 billion office skyscraper Monday, in a neighborhood that’s among Manhattan’s busiest — but is now still unusually quiet.The first tenants at One Vanderbilt, across from Grand Central Terminal, will start moving in by year’s end, SL Green Chief Executive Officer Marc Holliday said in an interview with Bloomberg Television.The tower’s big reveal comes at an awkward time for New York as many of the city’s workers stay home for fear of contracting the coronavirus. Landlords have been pressing business leaders to bring people back to their offices, and banks …read more […]

No Picture
Trading Ideas

Verizon buys Tracfone in $6.25B deal

September 14, 2020 admin Comments Off on Verizon buys Tracfone in $6.25B deal

On Monday Verizon, Yahoo Finance’s parent company, announced it is acquiring Tracfone, the leading pre-paid and value mobile provider in the U.S. for $6.25 billion in cash and stock. Ronan Dunne, Verizon Executive Vice President, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss. …read more […]

Newsmakers

CloudMD (OTC: DOCRF) to Acquire iMD Health Global Corp., a Revolutionary Patient Engagement Software Company

September 14, 2020 admin Comments Off on CloudMD (OTC: DOCRF) to Acquire iMD Health Global Corp., a Revolutionary Patient Engagement Software Company

Award-winning patient engagement software providing peer- reviewed, educational resources for patients about their conditions and treatment plans Access to 7.5 million patients, with over 10,000 healthcare professionals and other users, and 60 healthcare associations globally […]

No Picture
Trading Ideas

Oracle’s partnership with TikTok’s U.S. ops ‘doesn’t solve any problems’ but provides a ‘huge uptick’: cybersecurity expert

September 14, 2020 admin Comments Off on Oracle’s partnership with TikTok’s U.S. ops ‘doesn’t solve any problems’ but provides a ‘huge uptick’: cybersecurity expert

On Monday, treasury secretary Steven Mnuchin confirmed that the White House received Oracle’s proposal for TikTok and that the Trump administration will review it this week. Karim Hijazi, Prevailion CEO, joins Yahoo Finance’s The First Trade with Alexis Christoforous and Brian Sozzi to discuss. Hijazi also weighs in on the potential hacking risks in the lead-up to the 2020 U.S. presidential election. …read more […]

No Picture
Trading Ideas

These 3 Penny Stocks Could Double (Or More), Says BTIG

September 14, 2020 admin Comments Off on These 3 Penny Stocks Could Double (Or More), Says BTIG

After an epic rally to all-time highs, the stock market has been seesawing between the red and the green. The volatility that has ensued wasn’t driven by overtly negative news; progress on a COVID-19 vaccine is being made and economic data has been better-than-expected.BTIG’s Julian Emanuel argues that fewer “upside surprises” could be causing investor focus to shift to “arguably extended valuations and uncertainties surrounding ongoing stimulus negotiations, the 2020 Election, and simmering U.S./China tensions.”To this end, Emanuel suggests investors take advantage of any weakness and snap up healthcare stocks. “On Health Care, the sector is at an extremely attractive …read more […]

No Picture
Trading Ideas

Gilead Ramps Up Cancer Focus With $21 Billion Immunomedics Deal

September 14, 2020 admin Comments Off on Gilead Ramps Up Cancer Focus With $21 Billion Immunomedics Deal

(Bloomberg) — Gilead Sciences Inc. agreed to acquire Immunomedics Inc. for about $21 billion, a substantial premium for the maker of a promising breast-cancer therapy, and another big bet by Gilead that an innovative tumor-fighting drug can boost its fortunes.The proposed $88-a-share deal values Immunomedics at more than twice its closing price of $42.25 on Friday. The New Jersey-based company makes a breast-cancer treatment called Trodelvy that gained approval from the U.S. Food and Drug Administration in April. Since then, its stock has soared on bets that the clearance could make Immunomedics an attractive takeover target.Trodelvy’s approval came after clinical …read more […]